Multicenter, Prospective, Randomised and Comparative Study of AA Therapy and Early Administrating Enzalutamide in Participants With CRPC Previously Treated With CAB Therapy Using Bicalutamide.
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 28 Mar 2018
At a glance
- Drugs Enzalutamide (Primary) ; Flutamide (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- 22 Mar 2018 Planned primary completion date changed from 1 Sep 2018 to 1 Aug 2018.
- 22 Mar 2018 Status changed from recruiting to active, no longer recruiting.
- 10 Jun 2017 Biomarkers information updated